Statements (25)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Daphne_Zohar
|
gptkbp:country |
gptkb:United_States
|
gptkbp:focusesOn |
immunology
neurology oncology biotherapeutics development of medicines |
gptkbp:foundedYear |
2005
|
gptkbp:founder |
gptkb:Daphne_Zohar
|
gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
PureTech Health
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:listedOn |
gptkb:London_Stock_Exchange
|
gptkbp:market |
gptkb:FTSE_250_Index
|
gptkbp:numberOfEmployees |
100-200
|
gptkbp:stockSymbol |
gptkb:PRTC
|
gptkbp:subsidiary |
gptkb:Akili_Interactive
gptkb:Gelesis gptkb:Karuna_Therapeutics gptkb:Vedanta_Biosciences |
gptkbp:type |
gptkb:public_company
|
gptkbp:website |
https://www.puretechhealth.com/
|
gptkbp:bfsParent |
gptkb:Robert_Langer
|
gptkbp:bfsLayer |
3
|